Ralf Zahn1 *, MD FESC; Christoph A. Nienaber2 , MD FESC FACC; Christian W. Hamm3 , MD FESC FACC; Frank Weber2 , MD; Uwe Zeymer4 , MD FESC; Malte Kelm5 , MD FESC; Benny Levenson6 , MD; Tassilo Bonzel7 , MD; Ulrich Tebbe8 , MD FESC; Georg Sabin9 , MD; Gert Richardt10 , MD; Jochen Senges4 , MD FESC FACC for the German Cypher Stent Registry
1. Klinikum Süd, Kardiologie, Nürnberg, Germany; 2. Universitätsklinikum, Kardiologie, Rostock, Germany; 3. Kerckhoff Klinik, Kardiologie, Bad Nauheim, Germany; 4. Herzzentrum, Kardiologie, Ludwigshafen, Germany; 5. Universitätsklinikum, Kardiologie, Aach
Aims: When using bare metal stents (BMS), direct stenting (DS) has become an established method for percutaneous coronary interventions (PCI). If drug-eluting stents are used, DS is current
Sign in to read and download the full article
Login Forgot your password? No account yet? Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
coronary angioplasty direct stenting clinical research clinical practice sirolimus
Read next article
Advantage of sirolimus-eluting stents compared to intracoronary radiation therapy 30 months after treatment of in-stent restenosis